Megetra 160mg Tablet
Marketer
Getwell Pharma (I) Pvt Ltd
Salt Composition
Megestrol (160mg)
Overview Megetra 160mg Tablet
Medrolin 160mg tablets are indicated for the management of hormone-receptor-positive breast and endometrial cancers. This medication can also address decreased appetite and weight loss associated with advanced cancer or HIV. Dosage and duration of Medrolin 160mg therapy should be determined by your physician. Administration with or without food is acceptable, though consistent timing is recommended. Continue treatment as directed. Frequently reported side effects include increased appetite and weight, dyspnea, vasomotor flushes, hypertension, and constipation. These are usually transient, resolving with continued treatment. Report any persistent or troublesome side effects to your doctor; management strategies may be available. Inform your physician of all concurrent medications, as interactions may affect Medrolin's efficacy or pharmacokinetics. This medication is contraindicated during pregnancy and lactation. Regular blood tests to monitor hormone and glucose levels may be conducted during treatment.
Primary Ingredients of Megetra 160mg Tablet
No text provided to rephrase.
Uses of Megetra 160mg Tablet
Cancers of the breast and uterine lining
Major Benefits of Megetra 160mg Tablet:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Megetra 160mg Tablets can be consumed with or without food, although consistent timing is recommended.
Common Side effects of Megetra 160mg Tablet:
- Increased appetite
- Weight gain
- Hot flashes
- High blood pressure
- Constipation
How to use Megetra 160mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the 160mg Megetra tablet whole; avoid chewing, crushing, or fracturing it. Consumption may coincide with meals or be taken independently, though consistent timing is recommended.
How Megetra 160mg Tablet works:
Megetra 160mg tablets contain a progestin, a type of female hormone. In individuals with breast or endometrial cancer, this medication modifies hormone levels implicated in tumor development. A potential side effect is weight increase, often linked to heightened appetite.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Megetra 160mg Tablet may pose unknown risks. Seek medical advice before combining them.
PregnancyUNSAFE
Use of Megetra 160mg tablets is strongly contraindicated during pregnancy. Pregnant women should consult their physician; animal and human studies reveal substantial risks to fetal development.
Breast feedingCONSULT YOUR DOCTOR
The use of Megetra 160mg tablets while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Megetra 160mg Tablets.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Megetra 160mg tablets. Dosage modification for Megetra 160mg tablets may be necessary; physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should exercise caution when using Megetra 160mg tablets. Dosage modification for Megetra 160mg tablets may be necessary. Physician consultation is advised.
What if you forget to take Megetra 160mg Tablet :
NA
Facts to Know About Megetra 160mg Tablet
| Label | Value |
|---|---|
| Chemical Classification | Synthetic Progestins |
| Developing Habits | No. |
| Type of Therapy | Cancer Medications |


